At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 59 enrolled
Drug / intervention
Xenaderm +1 moredrug
Likely dose
Xenaderm 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment
In Brief
A Phase 1 clinical trial evaluating Ointment Vehicle and Xenaderm for Healthy. Completed, enrolled 59 participants across 1 site.
Detailed Summary
The product is being tested to see if exposure to light causes photoallergic reactions on the skin.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2008
First PostedMar 2008
Primary CompletionMay 2008
Study CompletionJun 2008
TodayJul 2026
First PostedMar 27, 2008
Enrollment StartMar 1, 2008
Primary CompletionMay 1, 2008
Study CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 18.3 years ago
Interventions
Ointment Vehicleother
Subject acts as own control. 20 mg under Finn chambers
Xenadermdrug
20 mg under Finn chambers